Sangamo Therapeutics Inc

SGMO

Equity

ISIN null / Valor 1066659

NASDAQ (2025-10-21)

USD 0.64-4.52%

Sangamo Therapeutics Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Sangamo Therapeutics Inc is a genomic medicine company focused on developing innovative treatments for severe diseases with limited treatment options. The company's mission is to utilize cutting-edge science to create transformative therapies that improve the lives of patients. Sangamo aims to address unmet medical needs and provide hope for individuals suffering from debilitating conditions.

Summarized from source with an LLMView SourceSector:

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-29.4%1Y

-85.1%3Y

-93.8%5Y

Performance

142%1Y

124%3Y

106%5Y

Volatility